World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
27406
World Ranking
13195
National Ranking
430

Overview

Ian G. Campbell is affiliated with the Peter MacCallum Cancer Centre in Australia. Their research spans multiple areas within biochemistry, genetics, molecular biology, and medicine, with a total of 134 publications in Biochemistry, Genetics and Molecular Biology and 110 in Medicine.

The scientist's main subfields of study include:

  • Genetics
  • Oncology
  • Molecular Biology
  • Cancer Research
  • Reproductive Medicine

Key topics covered in their work are:

  • BRCA gene mutations in cancer
  • Ovarian cancer diagnosis and treatment
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • DNA Repair Mechanisms
  • Genomics and Rare Diseases
  • Genetic Associations and Epidemiology

Ian G. Campbell has contributed to recent papers including:

  • Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes, 2020, Nature Genetics
  • Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants, 2020, Genetics in Medicine
  • Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities, 2020, The Journal of Pathology
  • Mescaline: The forgotten psychedelic, 2022, Neuropharmacology
  • Therapeutic options for mucinous ovarian carcinoma, 2020, Gynecologic Oncology

Frequent co-authors collaborating with Ian G. Campbell are:

  • Paul A. James
  • Kylie L. Gorringe
  • Lisa Devereux
  • Anna DeFazio
  • Irene L. Andrulis

Their publications often appear in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Breast Cancer
  • Clinical Cancer Research
  • Cancer Research
  • European Journal of Human Genetics

Best Publications

  • Mutation of the PIK3CA gene in ovarian and breast cancer.

    Ian G. Campbell;Sarah E. Russell;David Y. H. Choong;Karen G. Montgomery

  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson

  • Co-evolution of tumor cells and their microenvironment.

    Kornelia Polyak;Izhak Haviv;Ian G. Campbell;Ian G. Campbell

  • The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors.

    Amanda J. Philp;Ian G. Campbell;Christine Leet;Elizabeth Vincan

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Folate-binding Protein Is a Marker for Ovarian Cancer

    Ian G. Campbell;Tania A. Jones;William D. Foulkes;John Trowsdale

  • Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors

    Koshiro Obata;Sarah J. Morland;Richard H. Watson;Andrew Hitchcock

  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

    Viviana Galimberti;Bernard F Cole;Giuseppe Viale;Giuseppe Viale;Paolo Veronesi;Paolo Veronesi

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

    Paul D.P. Pharoah;Ya Yu Tsai;Susan J. Ramus;Catherine M. Phelan

  • CONTRA: copy number analysis for targeted resequencing

    Jason Li;Richard Lupat;Kaushalya C. Amarasinghe;Ella R. Thompson

  • Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.

    P. Garin-Chesa;I. Campbell;P. E. Saigo;J. L. Lewis

  • A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

    Ellen L Goode;Georgia Chenevix-Trench;Honglin Song;Susan J Ramus

  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

    Roger L Milne;Roger L Milne;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Kyriaki Michailidou;Kyriaki Michailidou;Jonathan Beesley

  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

    Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

  • Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

    R Coleman;R. De Boer;H. Eidtmann;A. Llombart

  • SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer

    Marjan E. Askarian-Amiri;Joanna Crawford;Juliet D. French;Chanel E. Smart

  • No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas

    Wen Qiu;Min Hu;Anita Sridhar;Ken Opeskin;Ken Opeskin

  • Dose-Response Association of CD8(+) Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

    Ellen L. Goode;Matthew S. Block;Kimberly R. Kalli;Robert A. Vierkant

  • Common variants at 19p13 are associated with susceptibility to ovarian cancer.

    Kelly L Bolton;Kelly L Bolton;Jonathan Tyrer;Honglin Song;Susan J Ramus

Frequent Co-Authors

Susan J. Ramus
Susan J. Ramus University of New South Wales
Graham G. Giles
Graham G. Giles University of Melbourne
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute
Melissa C. Southey
Melissa C. Southey Monash University
Diana Eccles
Diana Eccles University of Southampton
Paul D.P. Pharoah
Paul D.P. Pharoah University of Cambridge
Beth Y. Karlan
Beth Y. Karlan University of California, Los Angeles
Jan Lubinski
Jan Lubinski Pomeranian Medical University
Ellen L. Goode
Ellen L. Goode Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to diverse healthcare roles and flexible learning opportunities. Many students consider alternative or supplementary online programs, such as nursing, medical billing and coding, and healthcare administration. For those seeking accessible entry, some prospective nurses look for what is the easiest nursing school to get into to start their career quickly.

Financial challenges are top of mind for many learners. If you’re interested in administrative or support roles, explore options for financial aid for medical billing and coding. These programs often lead to stable medical careers without years of study.

Standardized tests can be a barrier, but there are nursing schools that don't require teas test, offering a smoother path for motivated students.

For those interested in leadership or management, a healthcare administration degree can unlock jobs in hospital administration and public health. Exploring these pathways can help you tailor your healthcare education to your goals and circumstances.

Best Scientists Citing Ian G. Campbell

Trending Scientists